You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

ALVOGEN Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ALVOGEN, and what generic and branded alternatives to ALVOGEN drugs are available?

ALVOGEN has fifty-seven approved drugs.

There are two tentative approvals on ALVOGEN drugs.

Drugs and US Patents for ALVOGEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen ESTRADIOL estradiol CREAM;VAGINAL 209767-001 Mar 5, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE buprenorphine hydrochloride; naloxone hydrochloride FILM;BUCCAL, SUBLINGUAL 205954-004 Jan 24, 2019 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen BUPRENORPHINE buprenorphine FILM, EXTENDED RELEASE;TRANSDERMAL 207490-004 May 17, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen FELBAMATE felbamate TABLET;ORAL 204595-001 Jan 11, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen TOLCAPONE tolcapone TABLET;ORAL 207729-001 Jul 29, 2020 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 202677-003 Mar 8, 2016 AA RX No No ⤷  Try a Trial ⤷  Try a Trial
Alvogen BUPRENORPHINE HYDROCHLORIDE buprenorphine hydrochloride FILM;BUCCAL 211594-005 Aug 3, 2021 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ALVOGEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 4,642,384 ⤷  Try a Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 4,066,755 ⤷  Try a Trial
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 4,005,209 ⤷  Try a Trial
Alvogen LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930 ⤷  Try a Trial
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 4,642,384 ⤷  Try a Trial
Alvogen TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,066,755 ⤷  Try a Trial
Alvogen TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 4,642,384 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.